Compare FDBC & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FDBC | TKNO |
|---|---|---|
| Founded | 1902 | 1996 |
| Country | United States | United States |
| Employees | 324 | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8M | 268.1M |
| IPO Year | 2000 | 2021 |
| Metric | FDBC | TKNO |
|---|---|---|
| Price | $53.97 | $9.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.0K | ★ 201.7K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | 35.00 | ★ 43.86 |
| EPS | ★ 2.63 | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | $20.80 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $39.87 | $1.91 |
| 52 Week High | $56.90 | $9.41 |
| Indicator | FDBC | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 55.64 | 80.33 |
| Support Level | $52.83 | $2.71 |
| Resistance Level | $56.52 | N/A |
| Average True Range (ATR) | 1.37 | 0.51 |
| MACD | -0.01 | 0.21 |
| Stochastic Oscillator | 75.19 | 94.13 |
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), the company provides a full range of banking, trust and financial services to individuals, small businesses and corporate customers. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. The company's segments include: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate, with the majority of revenue generating from the Commercial Real Estate segment.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.